SummaryBackgroundCraniofacial fibrous dysplasia has not only esthetic but functional impact. Surgery is controversial, ranging from conservative to radical. It involves elevated hemorrhage risk, and should be progressive, based on an individual risk/benefit analysis with the aim of improving quality of life.Case reportsThree patients (one male, two female; mean age, 35years) with evolutive orbital-temporal maxillary dysplasia were treated between 2008 and 2009 in our department. All showed exophthalmia and nasal obstruction. In one patient, symptomatology was aggravated by a frontal sinus cyst within the dysplasia. Another had associated auditory canal obstruction inducing recurrent external otitis. Optic nerve decompression was achieved on...
Introduction Historically, access to the anterior skull base was achieved with open procedures. The ...
Introduction Historically, access to the anterior skull base was achieved with open procedures. The ...
Fibrous dysplasia (FD) is a disturbance of the mesenchymal tissue that accounts for 2.5% of all bone...
SummaryBackgroundCraniofacial fibrous dysplasia has not only esthetic but functional impact. Surgery...
Background: The Craniofacial Fibrous Dysplasia is a benign disease, pseudoneoplasic, rare and asympt...
Background: The Craniofacial Fibrous Dysplasia is a benign disease, pseudoneoplasic, rare and asympt...
Fibrous dysplasia is a benign but slowly progressive disorder of bone in which normal cancellous bon...
Fibrous dysplasia (FD) is a fibrous lesion of immature bone, with an incidence of 10-20% in the head...
PURPOSE: To describe the multidisciplinary diagnosis and treatment of patients with orbital fibrous ...
Fibrous dysplasia (FD) is a benign bone tumor which most commonly involves the craniofacial skeleton...
A 10-year-old boy with progressive left visual disturbance associated with craniobasal fibrous dyspl...
Aim: To present the clinical features and management outcomes in a large longitudinal series of pati...
OBJECTIVE: The aim of this study is to report personal experience on the evolution of the therapeuti...
AbstractFibrous dysplasia is an uncommon benign tumour in the nasal cavity. Due to adjacent vital so...
Fibrous dysplasia (FD) is a non-malignant condition caused by post-zygotic, activating mutations of ...
Introduction Historically, access to the anterior skull base was achieved with open procedures. The ...
Introduction Historically, access to the anterior skull base was achieved with open procedures. The ...
Fibrous dysplasia (FD) is a disturbance of the mesenchymal tissue that accounts for 2.5% of all bone...
SummaryBackgroundCraniofacial fibrous dysplasia has not only esthetic but functional impact. Surgery...
Background: The Craniofacial Fibrous Dysplasia is a benign disease, pseudoneoplasic, rare and asympt...
Background: The Craniofacial Fibrous Dysplasia is a benign disease, pseudoneoplasic, rare and asympt...
Fibrous dysplasia is a benign but slowly progressive disorder of bone in which normal cancellous bon...
Fibrous dysplasia (FD) is a fibrous lesion of immature bone, with an incidence of 10-20% in the head...
PURPOSE: To describe the multidisciplinary diagnosis and treatment of patients with orbital fibrous ...
Fibrous dysplasia (FD) is a benign bone tumor which most commonly involves the craniofacial skeleton...
A 10-year-old boy with progressive left visual disturbance associated with craniobasal fibrous dyspl...
Aim: To present the clinical features and management outcomes in a large longitudinal series of pati...
OBJECTIVE: The aim of this study is to report personal experience on the evolution of the therapeuti...
AbstractFibrous dysplasia is an uncommon benign tumour in the nasal cavity. Due to adjacent vital so...
Fibrous dysplasia (FD) is a non-malignant condition caused by post-zygotic, activating mutations of ...
Introduction Historically, access to the anterior skull base was achieved with open procedures. The ...
Introduction Historically, access to the anterior skull base was achieved with open procedures. The ...
Fibrous dysplasia (FD) is a disturbance of the mesenchymal tissue that accounts for 2.5% of all bone...